209 related articles for article (PubMed ID: 15327424)
1. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
[TBL] [Abstract][Full Text] [Related]
2. Early application of Met-RANTES ameliorates chronic allograft nephropathy.
Song E; Zou H; Yao Y; Proudfoot A; Antus B; Liu S; Jens L; Heemann U
Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
[TBL] [Abstract][Full Text] [Related]
6. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
[TBL] [Abstract][Full Text] [Related]
7. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection.
Koch M; Poehnert D; Nashan B
Transpl Immunol; 2016 Mar; 35():12-7. PubMed ID: 26802360
[TBL] [Abstract][Full Text] [Related]
8. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
Dragun D; Böhler T; Nieminen-Kelhä M; Waiser J; Schneider W; Haller H; Luft FC; Budde K; Neumayer HH
Kidney Int; 2004 Mar; 65(3):1076-83. PubMed ID: 14871428
[TBL] [Abstract][Full Text] [Related]
9. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
[TBL] [Abstract][Full Text] [Related]
10. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
Mayer K; Birnbaum F; Reinhard T; Reis A; Braunstein S; Claas F; Sundmacher R
Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
[TBL] [Abstract][Full Text] [Related]
11. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
[TBL] [Abstract][Full Text] [Related]
12. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
13. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
Kimura T; Hasegawa T; Nakai H; Azuma T; Usui N; Sasaki T; Okada A
Transplantation; 2003 May; 75(9):1469-74. PubMed ID: 12792499
[TBL] [Abstract][Full Text] [Related]
14. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
15. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival.
Yanagawa Y; Hoshino Y; Chiba K
Int J Immunopharmacol; 2000 Aug; 22(8):597-602. PubMed ID: 10988354
[TBL] [Abstract][Full Text] [Related]
16. Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
Hirt SW; von Suesskind-Schwendi M; Puehler T; Schmid C; Lehle K
Transplant Proc; 2013 Mar; 45(2):783-6. PubMed ID: 23498820
[TBL] [Abstract][Full Text] [Related]
17. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
[TBL] [Abstract][Full Text] [Related]
18. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.
Li XK; Tamura A; Fujino M; Guo L; Kakefuda T; Funeshima N; Enosawa S; Amari M; Naoe S; Amemiya H; Suzuki S
Clin Exp Immunol; 2001 Feb; 123(2):331-9. PubMed ID: 11207666
[TBL] [Abstract][Full Text] [Related]
19. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
20. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
Sugito K; Inoue M; Ikeda T; Hagiwara N; Koshinaga T; Kusafuka T
Transplant Proc; 2007 Dec; 39(10):3432-5. PubMed ID: 18089399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
